Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Pope

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Seminars in Arthritis and Rheumatism|May 12, 2018
A systematic review of viral exposures as a risk for rheumatoid arthritisF M Kudaeva, M R Speechley, J E Pope
Archives of Internal Medicine|February 22, 1993
A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressureJ E Pope, J J Anderson, D T Felson
The Journal of Rheumatology|September 11, 1998
The development of rheumatoid arthritis after recombinant hepatitis B vaccinationJ E Pope, A Stevens, W Howson, et al.
Clinical and Experimental Rheumatology|April 16, 2004
Treatment of osteoarthritis of the hip and knee: a comparison of NSAID use in patients for whom surgery was and was not recommendedJ E Pope, K McCrea, A Stevens, et al.
Community Dental Health|June 1, 1995
The dental health of single male hostel dwellers in LeedsT Blackmore, S A Williams, M J Prendergast, et al.
Rheumatology (Oxford, England)|June 3, 2009
Digital ulcers: overt vascular disease in systemic sclerosisV Steen, C P Denton, J E Pope, et al.
Scandinavian Journal of Rheumatology|March 22, 2014
Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohortM Jung, A Bonner, M Hudson, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1994
Platelet calcium transport in hypertensionW L Dean, J E Pope, M E Brier, et al.
Lancet (London, England)|February 14, 1981
Plasma-trifluoperazine concentrations during high dose therapyS H Curry, R B Stewart, P K Springer, et al.
Arthritis and Rheumatism|August 18, 2001
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosisA E Thompson, B Shea, V Welch, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Seminars in Arthritis and Rheumatism|May 12, 2018
A systematic review of viral exposures as a risk for rheumatoid arthritisF M Kudaeva, M R Speechley, J E Pope
Archives of Internal Medicine|February 22, 1993
A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressureJ E Pope, J J Anderson, D T Felson
The Journal of Rheumatology|September 11, 1998
The development of rheumatoid arthritis after recombinant hepatitis B vaccinationJ E Pope, A Stevens, W Howson, et al.
Clinical and Experimental Rheumatology|April 16, 2004
Treatment of osteoarthritis of the hip and knee: a comparison of NSAID use in patients for whom surgery was and was not recommendedJ E Pope, K McCrea, A Stevens, et al.
Community Dental Health|June 1, 1995
The dental health of single male hostel dwellers in LeedsT Blackmore, S A Williams, M J Prendergast, et al.
Rheumatology (Oxford, England)|June 3, 2009
Digital ulcers: overt vascular disease in systemic sclerosisV Steen, C P Denton, J E Pope, et al.
Scandinavian Journal of Rheumatology|March 22, 2014
Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohortM Jung, A Bonner, M Hudson, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1994
Platelet calcium transport in hypertensionW L Dean, J E Pope, M E Brier, et al.
Lancet (London, England)|February 14, 1981
Plasma-trifluoperazine concentrations during high dose therapyS H Curry, R B Stewart, P K Springer, et al.
Arthritis and Rheumatism|August 18, 2001
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosisA E Thompson, B Shea, V Welch, et al.
Pageof 8